SMR analysis results suggested that a higher expression level of PCSK9 in whole blood was associated with a lower risk of IPF (OR = 0.71, 95% CI: 0.50 – 0.99, P = 0.043) (Table S20). Here, PCSK9 is linked to idiopathic pulmonary fibrosis.